• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSL 25.0% 0.5¢

ONCOSIL MEDICAL LTD - Corporate Spotlight

OncoSil Medical Ltd is an Australia-based medical device company seeking to advance... OncoSil Medical Ltd is an Australia-based medical device company seeking to advance radiation for cancer patients. The Company is focused on the development and commercialization of its lead product candidate, OncoSil localized radiation therapy, for the treatment of pancreatic and distal cholangiocarcinoma. OncoSil is a targeted radioactive isotope (Phosphorus-32), implanted directly into a patient’s pancreatic tumors through an endoscopic ultrasound. OncoSil is a single-use brachytherapy device that has received breakthrough device designation in the European Union, the United Kingdom, and the United States for the treatment of unresectable locally advanced pancreatic cancer in combination with chemotherapy. OncoSil comprises phosphorous-32 microparticles suspended in a specially formulated diluent. OncoSil is indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy.More

No Corporate Spotlight currently available.

(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $11.27M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $9.921K 2.075M

Buyers (Bids)

No. Vol. Price($)
36 15119267 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 2333627 4
View Market Depth
Last trade - 15.56pm 29/04/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 12.5 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 484933
Last updated 15.52pm 29/04/2024 ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.